Elsea Laboratory (Baylor College Of Medicine)
General information
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 252
Gene
| Gene | Submissions | Last Updated |
|---|---|---|
| AASS | 2 | Apr 7, 2020 |
| ABAT | 6 | Feb 19, 2019 |
| ABCC8 | 1 | Apr 7, 2020 |
| ABCD4 | 1 | Apr 7, 2020 |
| ABHD14A-ACY1 | 3 | Apr 7, 2020 |
| ABHD5 | 1 | Apr 7, 2020 |
| ACADL | 2 | Apr 7, 2020 |
| ACADM | 1 | Apr 7, 2020 |
| ACADS | 1 | Apr 7, 2020 |
| ACADSB | 1 | Apr 7, 2020 |
| ACVR2A | 4 | Feb 5, 2016 |
| ACY1 | 3 | Apr 7, 2020 |
| ALDH4A1 | 1 | Apr 7, 2020 |
| ALDH5A1 | 105 | May 16, 2024 |
| ALDH7A1 | 2 | Apr 7, 2020 |
| ALDOB | 2 | Apr 7, 2020 |
| ARG1 | 2 | Apr 7, 2020 |
| ASS1 | 1 | Apr 7, 2020 |
| AUH | 2 | Apr 7, 2020 |
| BCKDHA | 1 | Apr 7, 2020 |
| BCKDHB | 1 | Apr 7, 2020 |
| BTD | 3 | Apr 7, 2020 |
| CPS1 | 1 | Apr 7, 2020 |
| D2HGDH | 1 | Apr 7, 2020 |
| DDC | 3 | Apr 7, 2020 |
| DDC-AS1 | 2 | Apr 7, 2020 |
| DGAT1 | 2 | Apr 7, 2020 |
| DHTKD1 | 3 | Apr 7, 2020 |
| DMGDH | 1 | Apr 7, 2020 |
| DPYD | 1 | Apr 7, 2020 |
| ECHS1 | 2 | Apr 7, 2020 |
| EPC2 | 2 | Feb 5, 2016 |
| FAR1 | 2 | Apr 7, 2020 |
| GALT | 1 | Apr 7, 2020 |
| GAMT | 1 | Apr 7, 2020 |
| GCH1 | 2 | Apr 7, 2020 |
| GLDC | 4 | Apr 7, 2020 |
| GLYCTK | 2 | Apr 7, 2020 |
| GPLD1 | 13 | May 16, 2024 |
| HACL1 | 1 | Apr 7, 2020 |
| HDAC4 | 2 | Sep 4, 2020 |
| HIBCH | 6 | Apr 7, 2020 |
| HPRT1 | 1 | Apr 7, 2020 |
| HSD17B10 | 1 | Apr 7, 2020 |
| HSD17B4 | 2 | Apr 7, 2020 |
| HTRA2 | 1 | Apr 7, 2020 |
| KIF5C | 1 | Feb 5, 2016 |
| KYNU | 1 | Feb 5, 2016 |
| LIPA | 1 | Apr 7, 2020 |
| LIPT1 | 2 | Apr 7, 2020 |
| LOC129934143 | 1 | Apr 7, 2020 |
| LOC129995978 | 14 | May 16, 2024 |
| LOC130001383 | 1 | Apr 7, 2020 |
| LOC130055692 | 1 | Apr 7, 2020 |
| LOC130062945 | 1 | Apr 7, 2020 |
| LRP1B | 1 | Feb 5, 2016 |
| MBD5 | 9 | Feb 5, 2016 |
| MCCC1 | 1 | Apr 7, 2020 |
| MCCC2 | 1 | Apr 7, 2020 |
| MED23 | 2 | Apr 7, 2020 |
| MITD1 | 2 | Apr 7, 2020 |
| MMACHC | 4 | Apr 7, 2020 |
| MMUT | 5 | Apr 7, 2020 |
| MOCS1 | 1 | Apr 7, 2020 |
| MTHFR | 1 | Apr 7, 2020 |
| MTR | 3 | Apr 7, 2020 |
| NAGS | 2 | Apr 7, 2020 |
| ORC4 | 6 | Feb 5, 2016 |
| OTC | 1 | May 16, 2024 |
| OXCT1 | 1 | Apr 7, 2020 |
| PAH | 2 | Apr 7, 2020 |
| PCCB | 1 | Apr 7, 2020 |
| PDHA1 | 2 | Apr 7, 2020 |
| PEX1 | 3 | Apr 7, 2020 |
| PEX13 | 1 | Apr 7, 2020 |
| PEX16 | 2 | Apr 7, 2020 |
| PEX2 | 1 | Apr 7, 2020 |
| PEX26 | 2 | Apr 7, 2020 |
| PEX3 | 1 | Apr 7, 2020 |
| PEX5 | 3 | Apr 7, 2020 |
| PEX6 | 1 | Apr 7, 2020 |
| PGK1 | 1 | Apr 7, 2020 |
| PYY | 2 | Apr 7, 2020 |
| QTMAN | 1 | Feb 5, 2016 |
| SERAC1 | 1 | Apr 7, 2020 |
| SLC22A5 | 1 | Apr 7, 2020 |
| SLC52A2 | 1 | Jun 26, 2020 |
| SLC5A6 | 1 | Dec 23, 2024 |
| SLC6A19 | 2 | Apr 7, 2020 |
| SUCLG1 | 2 | Apr 7, 2020 |
| TALDO1 | 1 | Apr 7, 2020 |
| TJP2 | 2 | Apr 7, 2020 |
| TRMU | 2 | Apr 7, 2020 |
| UPB1 | 4 | Apr 7, 2020 |
| UROC1 | 3 | Apr 7, 2020 |
| ZEB2 | 1 | Feb 5, 2016 |
Condition
Testing in GTR
| Disease name | Number of tests |
|---|---|
| 17p11.2 microduplication syndrome | 1 test |
| 2q23.1 microdeletion syndrome | 1 test |
| 2q23.1 microduplication syndrome | 1 test |
| Acid sphingomyelinase deficiency | 1 test |
| Autism spectrum disorder | 1 test |
| Chromosome 2q23.1 deletion syndrome | 1 test |
| Chromosome 2q23.1 duplication syndrome | 1 test |
| Chromosome 2q37 deletion syndrome | 1 test |
| Deficiency of aromatic-L-amino-acid decarboxylase | 2 tests |
| Developmental delay with variable intellectual impairment and behavioral abnormalities | 1 test |
| Hereditary orotic aciduria | 1 test |
| Intellectual disability, autosomal dominant 1 | 1 test |
| Niemann-Pick disease, type C | 1 test |
| Pitt-Hopkins syndrome | 1 test |
| Pyridoxine-dependent epilepsy | 1 test |
| Smith-Magenis syndrome | 1 test |
| Succinate-semialdehyde dehydrogenase deficiency | 2 tests |
